Search Results - "Cohen‐Ezra, Oranit"
-
1
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients
Published in Liver transplantation (01-02-2022)“…The BNT162b2 messenger RNA (mRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been shown to be safe and effective in…”
Get full text
Journal Article -
2
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
Published in mSystems (16-06-2020)“…Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors…”
Get full text
Journal Article -
3
Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: Could it be primary biliary cholangitis?
Published in Hepatology research (01-07-2017)“…Aim Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease, typically diagnosed by elevated cholestatic liver enzymes and a positive…”
Get full text
Journal Article -
4
Research trends analysis of chronic hepatitis C versus nonalcoholic fatty liver disease: A literature review text‐mining analysis of publications
Published in Health science reports (01-11-2022)“…Background Hepatits C virus (HCV) rates have lowered due to direct‐acting antiviral treatment. Nonalcoholic steatohepatitis (NASH)/nonalcoholic fatty liver…”
Get full text
Journal Article -
5
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Published in Nature Medicine (01-06-2021)“…Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are prevalent liver conditions that underlie the development of…”
Get full text
Journal Article Magazine Article -
6
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients
Published in Viruses (12-12-2022)“…The immune response of liver transplant (LT) recipients to a third dose of the BNT162b2 mRNA vaccine significantly waned after four months. We aimed to…”
Get full text
Journal Article -
7
Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Published in Nature Medicine (2022)“…In the version of this Article initially published, an electronic conversion error led to errors in the names of Michal Safran and Baoguo Li. Their names have…”
Get full text
Journal Article Magazine Article -
8
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
Published in Viruses (16-01-2023)“…The immune responses of liver transplant (LT) recipients after the third boost of the BNT162b2mRNA vaccine improved. This study evaluates the durability of the…”
Get full text
Journal Article -
9
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial
Published in BMC infectious diseases (03-04-2020)“…Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and hepatocellular carcinoma. Treatment with first generation protease inhibitors…”
Get full text
Journal Article -
10
HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
Published in Viruses (11-03-2022)“…A comprehensive characterization of chronic HBV (CHB) patients is required to guide therapeutic decisions. The cumulative impact of classical and novel…”
Get full text
Journal Article -
11
Prevalence of hepatitis E virus antibodies, Israel, 2009-2010
Published in Emerging infectious diseases (01-04-2015)“…We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95%…”
Get full text
Journal Article -
12
HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients
Published in Antiviral therapy (01-01-2017)“…Direct-acting antiviral (DAA) treatment regimens and response rates of patients with HCV genotype-1 (GT1) are currently considered subtype-dependent…”
Get more information
Journal Article -
13
Secondary sclerosing cholangitis following major burn
Published in Annals of hepatology (01-09-2015)“…AbstractBackground and aims. Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) is a relatively new previously unrecognized entity which may…”
Get full text
Journal Article -
14
Ciliated hepatic foregut cyst with high intra-cystic carbohydrate antigen 19-9 level
Published in World journal of gastroenterology : WJG (21-11-2014)“…A ciliated hepatic foregut cyst(CHFC)is a rare foregut developmental malformation usually diagnosed in adulthood.Five percent of reported cases of CHFC…”
Get full text
Journal Article -
15
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
Published in mSystems (16-06-2020)“…Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors…”
Get full text
Journal Article -
16
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
Published in Journal of hepatology (01-09-2022)“…Immune responses of solid organ transplant recipients to 2 doses of the BNT162b2 mRNA anti-SARS-CoV-2 vaccine are impaired. The immunogenicity and safety of a…”
Get full text
Journal Article -
17
Incorporating artificial intelligence in portable infrared thermal imaging for the diagnosis and staging of non-alcoholic fatty liver disease
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
18
-
19
Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data
Published in Journal of clinical oncology (01-06-2023)“…e16167 Background: Treatment of advanced unresectable hepatocellular carcinoma (HCC) has advanced substantially in the past few years with the use of…”
Get full text
Journal Article -
20
A third dose of the BNT162b2 mRNA vaccine significantly improved immune response among liver transplant recipients
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article